Thomas Flaten
Stock Analyst at Lake Street
(1.59)
# 2,942
Out of 4,670 analysts
30
Total ratings
33.33%
Success rate
-1.84%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Buy | $34 → $40 | $29.81 | +34.18% | 5 | Nov 5, 2024 | |
| DERM Journey Medical | Initiates: Buy | $9 | $5.37 | +67.60% | 1 | Sep 6, 2024 | |
| OPTN OptiNose | Maintains: Buy | $4 → $3 | $0.48 | +525.00% | 3 | May 15, 2024 | |
| PSNL Personalis | Initiates: Buy | $4 | $3.47 | +15.27% | 1 | Apr 30, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.94 | +218.88% | 3 | Mar 12, 2024 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $3 → $8 | $4.56 | +75.44% | 1 | Mar 7, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $4.29 | +156.41% | 3 | Mar 5, 2024 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $16 → $14 | $3.75 | +273.33% | 3 | Aug 16, 2023 | |
| BLFS BioLife Solutions | Maintains: Buy | $34 → $25 | $26.01 | -3.88% | 2 | Aug 9, 2023 | |
| EVAX Evaxion Biotech | Maintains: Buy | $180 → $70 | $1.49 | +4,597.99% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $60 → $10 | $2.71 | +269.00% | 4 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $960 → $96 | $0.43 | +22,225.58% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $4.70 | +70.21% | 1 | Jul 7, 2022 |
Castle Biosciences
Nov 5, 2024
Maintains: Buy
Price Target: $34 → $40
Current: $29.81
Upside: +34.18%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $5.37
Upside: +67.60%
OptiNose
May 15, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.48
Upside: +525.00%
Personalis
Apr 30, 2024
Initiates: Buy
Price Target: $4
Current: $3.47
Upside: +15.27%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.94
Upside: +218.88%
Aquestive Therapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $3 → $8
Current: $4.56
Upside: +75.44%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.29
Upside: +156.41%
Checkpoint Therapeutics
Aug 16, 2023
Maintains: Buy
Price Target: $16 → $14
Current: $3.75
Upside: +273.33%
BioLife Solutions
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $26.01
Upside: -3.88%
Evaxion Biotech
Mar 31, 2023
Maintains: Buy
Price Target: $180 → $70
Current: $1.49
Upside: +4,597.99%
Dec 1, 2022
Downgrades: Hold
Price Target: $60 → $10
Current: $2.71
Upside: +269.00%
Nov 17, 2022
Maintains: Buy
Price Target: $960 → $96
Current: $0.43
Upside: +22,225.58%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $4.70
Upside: +70.21%